๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A clinical and pharamcological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue

โœ Scribed by Mark McKeage; Peter Dady; Michael Clear; Allison MacDonald

Publisher
Springer
Year
1992
Tongue
English
Weight
664 KB
Volume
29
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hearing loss in children with brain tumo
Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue
โœ Freilich, Ronnie J.; Kraus, Dennis H.; Budnick, Amy S.; Bayer, Lisa A.; Finlay, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 602 KB

Carboplatin is less ototoxic than cisplatin, but ototoxicity may occur with carboplatin at higher doses. We evaluated hearing in children with brain tumors treated with conventional dose cisplatin followed by highdose carboplatin. Children under 6 years of age, newly diagnosed with brain tumors, wer

High-dose melphalan, vincristine, and to
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: A phase II study
โœ Pinkerton, C. R. ;Philip, T. ;Biron, P. ;Frapazz, D. ;Phillipe, N. ;Zucker, J. M ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 432 KB

Seven children with neuroblastoma who had relapsed on or after conventional therapy (3 originally stage IV, 3 stage III, 1 stage II) were entered on a study of "massive therapy" with purged autologous bone marrow rescue. In 5 patients attempts were made to reinduce remission with alternative chemoth

Quality of life in patients surviving at
Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support
โœ Eric P. Winer; Celeste Lindley; Melanee Hardee; William T. Sawyer; Caryn Brunatt ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

## Background: Over the past decade, high dose chemotherapy with autologous bone marrow (hdc-abmt) support has been used increasingly in the treatment of patients with breast cancer. in evaluating the results of hdc-abmt in patients with breast cancer, an assessment of quality of life can add to th